CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $41.90, but opened at $44.36. CochLear shares last traded at $44.05, with a volume of 1,775 shares.
Analyst Ratings Changes
Several analysts have commented on the company. Zacks Research raised CochLear from a “strong sell” rating to a “hold” rating in a report on Monday, June 22nd. UBS Group downgraded CochLear from a “strong-buy” rating to a “hold” rating in a research note on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.
View Our Latest Stock Report on CochLear
CochLear Stock Down 1.0%
About CochLear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Articles
- Five stocks we like better than CochLear
- 3 Quiet AI Revenue Accelerators With Sales Growth Outpacing Peers
- Top 135 Best Locally Owned BBQ Supply Stores in the U.S., According to Survey [2026]
- Silicon Starvation: Amazon Feasts on Legacy GPUs
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
